Showing results (241-250 of 387) with videos related to

Sort By:
Pageof 39
Comprehensive Psychiatry|November 26, 2016
Increase in PAS-induced neuroplasticity after a treatment course of intranasal ketamine for depression. Report of three cases from a placebo-controlled trialVerònica Gálvez, Stevan Nikolin, Kerrie-Anne Ho, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Disposition and removal of metronidazole in patients undergoing haemodialysisA Somogyi, C Kong, J Sabto, et al.
Pain|January 24, 2006
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrationsPeter Athanasos, Charlotte S Smith, Jason M White, et al.
Clinical Pharmacokinetics|January 1, 1981
Clinical pharmacokinetics of the non-depolarising muscle relaxantsM I Ramzan, A A Somogyi, J S Walker, et al.
Therapeutic Drug Monitoring|August 4, 2006
Stereoselective quantification of methadone and a d(6)-labeled isotopomer using high performance liquid chromatography-atmospheric pressure chemical ionization mass-spectrometry: application to a pharmacokinetic study in a methadone maintained subjectDavid J R Foster, Erin B Morton, Georg Heinkele, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2006
CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesBenjamin J Davies, Janet K Coller, Andrew A Somogyi, et al.
British Journal of Clinical Pharmacology|March 5, 2004
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesMark R Hutchinson, Andrew Menelaou, David J R Foster, et al.
La Revue De Medecine Interne|September 13, 2005
[Pravastatin-induced dermatomyositis]P Zuech, C Pauwels, C Duthoit, et al.
British Journal of Clinical Pharmacology|November 27, 2008
Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamicsAndrew A Somogyi, Mie Larsen, Reza M Abadi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2010
In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humansPritsana Raungrut, Verawan Uchaipichat, David J Elliot, et al.
Pageof 39